SAN MATEO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at the 12th Annual BIO CEO & Investor Conference, to be held February 8-9, 2010 at the Waldorf-Astoria Hotel in New York, New York.
